IWA
GILD icon

IVC Wealth Advisors’s Gilead Sciences GILD Stock Holding History

IVC Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$200K Sell
1,586
-1
-0.1% -$132 0.08% 176
2026
Q1 		$221K Buy
+1,587
New +$222K 0.1% 162
2025
Q3 		– Sell
-1,822
Closed -$202K – 188
2025
Q2 		$202K Sell
1,822
-123
-6% -$13.1K 0.1% 170
2025
Q1 		$218K Buy
+1,945
New +$201K 0.12% 147

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IVC Wealth Advisors's GILD Position: Q2 2026 in Review

IVC Wealth Advisors reduced its Gilead Sciences (GILD) stake by 0.06% in Q2 2026, selling an estimated $132 and leaving 1,586 shares worth $200K. The position accounts for 0.08% of the portfolio, ranked #176.

IVC Wealth Advisors first reported a position in GILD in Q1 2025 and has held it in 4 quarters since. The position peaked at $221K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • IVC Wealth Advisors held 1,586 shares of Gilead Sciences worth $200K as of Q2 2026.
  • IVC Wealth Advisors sold 1 Gilead Sciences share in Q2 2026, an estimated $132.
  • Gilead Sciences made up 0.08% of IVC Wealth Advisors's portfolio in Q2 2026, its #176 holding.
  • IVC Wealth Advisors first reported a position in Gilead Sciences in Q1 2025 and has held it in 4 quarters since.
  • IVC Wealth Advisors's Gilead Sciences position peaked at $221K in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on IVC Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.